|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2006.01) |
| A61K 31/7125 | (2006.01) | ||
| C12N 15/11 | (2006.01) |
| (11) | Number of the document | 2612917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11821996.3 |
| Date of filing the European patent application | 2011-08-31 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-24 |
| (46) | Date of publication of the claims translation | 2016-05-10 |
| (86) | Number | PCT/JP2011/070318 |
| Date | 2011-08-31 |
| (87) | Number | WO 2012/029986 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 2010196032 | 2010-09-01 | JP |
| (72) |
WATANABE, Naoki, JP
SATOU, Youhei, JP
TAKEDA, Shin`ichi, JP
NAGATA, Tetsuya, JP
|
| (73) |
Nippon Shinyaku Co., Ltd.,
14, Kisshoin Nishinosho Monguchicho Minami-ku, Kyoto-shi Kyoto 601-8550,
JP
National Center of Neurology and Psychiatry, 1-1, Ogawa-Higashi-cho, 4-chome, Kodaira-shi Tokyo 187-8551, JP |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antiprasminė nukleorūgštis |
| ANTISENSE NUCLEIC ACID |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 15 | 289.00 EUR |
| 2026-08-31 |